Patients with CHD or newly diagnosed acute coronary syndrome are at a high risk of recurrent coronary events. In addition to modification of lifestyle factors, LDL lowering has been shown to reduce recurrent events, cardiovascular deaths and all-cause mortality in these patients. According to the NCEP ATP III guidelines, LDL<unk>  of < 100 mg/dL is the goal in patients with CHD and CHD risk equivalents. The complete NCEP recommendations are reviewed here, in addition to the data supporting these recommendations.
High cholesterol secondary prevention
High cholesterol primary prevention
Blood cholesterol LDL and non-HDL treatment goals
Hyperlipidemia primary prevention
Diabetes mellitus type 2 secondary prevention
Chronic stable angina treatment lipid management
Diabetes primary prevention of cardiovascular events
Metabolic syndrome primary prevention